Results of network (frequentist and Bayes) analysis in Study 1: differences between Cohort A patients (burdened with conditions requiring antidepressants/anxyolytics and prescribed fluvoxamine around the time of COVID-19 diagnosis), i.e., treated; and Cohort B patients (suffer similar psychiatric difficulties, but are not prescribed with fluvoxamine), i.e., control patients, regarding the outcomes of interest (see Table 1 for cohort definitions, and Outcomes for outcome defiinitions). A Meta-analysis based on weighted proportions. Direct, indirect and total (combined, network) differences (relative risks, RR). B Meta-analysis based on Ln (RR) generated in primary Bayesian analysis with moderately informative skeptical prior (shown in Figure 2). Only total (combined) effects are shown (as in A, direct and indirect effects were consistent).